However, the authors pointed out that their results are derived from years in which clinical practice guidelines for GLP-1 RAs were emerging and might have impacted GLP-1 RA uptake
Of course, its important to note that your treatment plan may differ from this, depending on your personal circumstances
The American Diabetes Association (ADA) guidelines recommend specific GLP-1 agonists with proven cardiovascular benefit (such as liraglutide, injectable semaglutide, and dulaglutide) for patients with type 2 diabetes and established atherosclerotic cardiovascular disease
A patient injecting at the wrong time, on an arbitrary schedule, without monitoring is not getting the same protocol
Its as if youre not even taking it. Patients should use an additional barrier method, and women who become pregnant should stop the GLP-1 medication immediately